Overall, the use of these three drugs showed simultaneous inhibition of tumor cells, and it suggests that the upregulation of WNT/PD-L1 in acidic TME induced by MCT4 jointly constitutes the malignant phenotype of TNBC (Figure 3(e)). The gene discussed is CD274; the disease is neoplasm.